This seminar, organised by UNODC and the Colombian Ministry for Social Protection, will provide a space for national and international experts to reflect issues related to drugs and HIV, in order to draft a joint agenda with short, medium and long-term actions to prevent, treat and reduce the impact of drug injection on HIV and public health in Colombia.
This event will screen a documentary that follows the first year of a heroin-assisted treatment program in Denmark and will then discuss a similar program in Canada.
The main goal of the conference is to advocate for and promote harm reduction in the countries of the MENA region and to foster networking between civil society organisations and other stakeholders working in the field.
The seminar’s aim is to provide insights in newest developments in HCV testing and treatment opportunities, to present good practices of community and harm reduction based HCV activities and to exchange and discuss future opportunities.
The World Federation for the Treatment of Opioid Dependence and EUROPAD will select up to 12 oral presentations to be presented during the next American Association for the Treatment of Opioid Dependence congress
The intersessional meeting this autumn will focus on the expansion and diversification of drugs and drug markets, the historic rise of supply and demand, and the growing public health issues related to opioid use.
Webinar outlining how opioid stigma reduction programs can measure the behaviours of first responders and health-care providers towards people living with opioid use.
Welcome to the second edition of the IDPC Drug Policy Guide. The Guide brings together global evidence and examples of best practice to provide guidance on the review, design and implementation of national drug policies.
The report consists of a summary of the national drug situation presenting brief information in key areas (drugs prevalence, prevention, harm reduction, drug laws etc.).
This TNI briefing paper sheds light on the methamphetamine market in Southeast Asia and China, including patterns of supply and use. It highlights the urgent need for donors and governments to introduce effective harm reduction measures aimed at ATS users.
.pdf)
